Structures by: Wan J.
Total: 70
C30H48O5,0.5(CH2Cl2)
C30H48O5,0.5(CH2Cl2)
Journal of natural products (2017) 80, 11 2874-2882
a=9.8304(3)Å b=7.6333(2)Å c=20.2122(6)Å
α=90° β=102.819(2)° γ=90°
BMS-791325
C36H46ClN5O6S
Journal of medicinal chemistry (2014) 57, 5 1855-1879
a=28.0870(13)Å b=11.9998(6)Å c=10.9846(6)Å
α=90.00° β=90.761(2)° γ=90.00°
C29H27Br2NO5
C29H27Br2NO5
Organic letters (2011) 13, 6 1346-1349
a=8.5231(4)Å b=29.4273(12)Å c=11.1098(5)Å
α=90.00° β=98.976(3)° γ=90.00°
C17H19ClN2S
C17H19ClN2S
Organic letters (2006) 8, 12 2599-2602
a=9.0868(16)Å b=9.7252(18)Å c=9.8440(17)Å
α=90.00° β=107.272(13)° γ=90.00°
C25H21N3
C25H21N3
Organic & biomolecular chemistry (2020) 18, 5 975-982
a=11.6501(4)Å b=10.8130(3)Å c=16.4196(5)Å
α=90° β=106.886(4)° γ=90°
C24H19NO3S
C24H19NO3S
Chemical communications (Cambridge, England) (2018) 54, 99 13953-13956
a=16.2229(11)Å b=10.6431(5)Å c=12.0294(7)Å
α=90° β=98.650(5)° γ=90°
C30H46O6
C30H46O6
RSC Advances (2020) 10, 6 3343-3356
a=14.2747(19)Å b=6.4197(9)Å c=14.897(2)Å
α=90° β=105.303(9)° γ=90°
C30H44O6,3(H2O)
C30H44O6,3(H2O)
RSC Advances (2020) 10, 6 3343-3356
a=8.0649(6)Å b=11.3973(8)Å c=32.416(2)Å
α=90° β=90° γ=90°
C30H46O6
C30H46O6
RSC Advances (2020) 10, 6 3343-3356
a=13.9664(4)Å b=6.5552(2)Å c=15.1284(5)Å
α=90° β=104.366(2)° γ=90°
C31H50O6,H2O
C31H50O6,H2O
RSC Advances (2020) 10, 6 3343-3356
a=30.9220(6)Å b=13.9294(3)Å c=14.7361(3)Å
α=90° β=107.9170(10)° γ=90°
C12H10CdClN6O
C12H10CdClN6O
CrystEngComm (2016) 18, 27 5164
a=8.476(2)Å b=9.029(2)Å c=10.274(3)Å
α=73.979(3)° β=85.725(3)° γ=84.377(3)°
C12H8CdN7O3
C12H8CdN7O3
CrystEngComm (2016) 18, 27 5164
a=6.3373(8)Å b=10.7022(14)Å c=11.3187(15)Å
α=107.774(2)° β=95.235(2)° γ=104.2870(10)°
C14H13CdN6O3
C14H13CdN6O3
CrystEngComm (2016) 18, 27 5164
a=10.5519(14)Å b=12.7771(17)Å c=11.4874(15)Å
α=90.00° β=93.251(2)° γ=90.00°
C24H16Cd3N24
C24H16Cd3N24
CrystEngComm (2016) 18, 27 5164
a=21.508(4)Å b=14.936(3)Å c=10.109(2)Å
α=90.00° β=95.266(2)° γ=90.00°
C25H20Cd2N14O7
C25H20Cd2N14O7
CrystEngComm (2016) 18, 27 5164
a=24.090(2)Å b=14.7011(14)Å c=20.418(2)Å
α=90.00° β=122.3110(10)° γ=90.00°
C14H11Cd2N12O2
C14H11Cd2N12O2
CrystEngComm (2016) 18, 27 5164
a=13.076(8)Å b=12.914(8)Å c=11.690(7)Å
α=90.00° β=104.749(8)° γ=90.00°
Uranyl Deferiprone
UO2(C7O2N)2??5H2O
Dalton transactions (Cambridge, England : 2003) (2018) 47, 26 8764-8770
a=6.792(2)Å b=10.823(4)Å c=13.823(5)Å
α=86.128(12)° β=78.578(12)° γ=80.403(12)°
C24H21NO2
C24H21NO2
Chem.Commun. (2012) 48, 10049
a=9.6447(7)Å b=10.8414(8)Å c=18.1742(14)Å
α=90.00° β=90.00° γ=90.00°
1-(3-Nitrophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-one
C11H10N4O3
Acta Crystallographica Section E (2005) 61, 7 o1997-o1998
a=26.334(8)Å b=4.5962(13)Å c=9.570(3)Å
α=90.00° β=90.00° γ=90.00°
2-(1H-1,2,3-Benzotriazol-1-ylmethyl)-1-(4-chlorobenzoyl)ethyl 2,4-dichlorobenzoate
C22H14Cl3N3O3
Acta Crystallographica Section E (2006) 62, 7 o2793-o2794
a=11.941(3)Å b=25.588(6)Å c=13.780(3)Å
α=90.00° β=100.508(4)° γ=90.00°
2-(1H-Benzotriazol-1-yl)-1-(2,5-dichlorophenyl)-2-(1H-1,2,4-triazol-1- yl)ethanone
C16H10Cl2N6O
Acta Crystallographica Section E (2006) 62, 1 o356-o357
a=7.6217(6)Å b=8.6107(8)Å c=25.5989(19)Å
α=90.00° β=107.322(2)° γ=90.00°
2-(2-Fluoro-5-methylphenyl)-2-oxo-1-(1H-1,2,4-triazol-1-yl)ethyl morpholine-4-carbodithioate
C16H17FN4O2S2
Acta Crystallographica Section E (2006) 62, 1 o358-o359
a=6.7311(13)Å b=7.7910(15)Å c=18.107(4)Å
α=98.200(3)° β=92.649(4)° γ=109.900(3)°
2-(1H-1,2,3-Benzotriazol-1-ylmethyl)-1-(4-chlorobenzoyl)ethyl nicotinate
C21H15ClN4O3
Acta Crystallographica Section E (2006) 62, 6 o2302-o2303
a=18.820(2)Å b=5.3367(6)Å c=19.027(2)Å
α=90.00° β=90.00° γ=90.00°
1-(4-Nitrophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-one
C11H10N4O3
Acta Crystallographica Section E (2005) 61, 10 o3394-o3395
a=9.8529(7)Å b=5.4011(4)Å c=21.9132(14)Å
α=90.00° β=103.233(3)° γ=90.00°
2-(1H-Benzotriazol-1-yl))-1-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1- yl)ethanone
C16H10Cl2N6O
Acta Crystallographica Section E (2005) 61, 10 o3232-o3233
a=21.950(3)Å b=9.9632(15)Å c=15.538(2)Å
α=90.00° β=106.028(2)° γ=90.00°
1-(4-Methoxyphenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-one
C12H13N3O2
Acta Crystallographica Section E (2005) 61, 2 o307-o308
a=8.2642(13)Å b=11.4273(18)Å c=12.0990(19)Å
α=90.00° β=94.709(2)° γ=90.00°
1-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-1-one hemihydrate
C11H11N3O,0.5H2O
Acta Crystallographica Section E (2005) 61, 6 o1641-o1642
a=25.429(9)Å b=8.209(5)Å c=10.502(6)Å
α=90.00° β=95.595(9)° γ=90.00°
3-(1H-1,2,3-Benzotriazol-1-yl)-1-(4-methoxyphenyl)propan-1-one
C16H15N3O2
Acta Crystallographica Section E (2005) 61, 6 o1793-o1794
a=8.6112(9)Å b=21.669(2)Å c=8.1152(8)Å
α=90.00° β=106.820(2)° γ=90.00°
3-(1H-Imidazol-1-yl)1-phenylpropan-1-one
C12H12N2O
Acta Crystallographica Section E (2005) 61, 11 o3632-o3633
a=12.5860(14)Å b=10.3777(12)Å c=8.0771(9)Å
α=90.00° β=102.095(2)° γ=90.00°
2-(1H-Benzotriazol-1-yl)-1-phenyl-2-(1H-1,2,4-triazol-1-yl)ethanone cyclohexane hemisolvate
C16H12N6O,0.5C6H12
Acta Crystallographica Section E (2005) 61, 11 o3903-o3904
a=8.9187(12)Å b=8.3101(11)Å c=25.367(3)Å
α=90.00° β=108.718(4)° γ=90.00°
2-(2H-Benzotriazol-2-yl)-1-phenylethanone
C14H11N3O
Acta Crystallographica Section E (2005) 61, 12 o4056-o4057
a=8.1925(3)Å b=8.1925(3)Å c=35.462(3)Å
α=90.00° β=90.00° γ=90.00°
2-(1H-1,2,3-Benzotriazol-1-ylmethyl)-1-benzoylethyl 4-ethylbenzoate
C24H21N3O3
Acta Crystallographica Section E (2005) 61, 12 o4218-o4219
a=13.9064(9)Å b=8.7793(6)Å c=17.4342(12)Å
α=90.00° β=101.1430(10)° γ=90.00°
2-(1H-1,2,3-Benzotriazol-1-ylmethyl)-1-benzoylethyl 4-chlorobenzoate
C22H16ClN3O3
Acta Crystallographica Section E (2006) 62, 2 o634-o636
a=9.712(3)Å b=20.379(5)Å c=10.009(3)Å
α=90.00° β=90.392(4)° γ=90.00°
2-(1H-1,2,3-Benzotriazol-1-yl)-1-benzoylethyl 2-chlorobenzoate
C22H16ClN3O3
Acta Crystallographica Section E (2006) 62, 3 o1038-o1039
a=12.9341(9)Å b=9.4562(7)Å c=18.1878(9)Å
α=90.00° β=120.441(3)° γ=90.00°
1-(4-Chlorobenzoyl)-2-(1H-1,2,4-triazol-1-yl)ethyl morpholine-4-carbodithioate)
C16H17ClN4O2S2
Acta Crystallographica Section E (2006) 62, 3 o1081-o1083
a=16.8253(15)Å b=7.4853(7)Å c=14.8743(13)Å
α=90.00° β=97.1710(10)° γ=90.00°
2-(1H-1,2,3-Benzotriazol-1-yl)-1-benzoylethyl 2,4-dichlorobenzoate
C22H15Cl2N3O3
Acta Crystallographica Section E (2006) 62, 3 o1099-o1100
a=9.1235(12)Å b=9.4228(12)Å c=23.307(3)Å
α=90.00° β=90.916(2)° γ=90.00°
1-(4-Methylphenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-one
C12H13N3O
Acta Crystallographica Section E (2005) 61, 8 o2391-o2392
a=10.943(4)Å b=13.777(5)Å c=7.514(3)Å
α=90.00° β=90.00° γ=90.00°
Acetonyl morpholine-4-carbodithioate
C8H13NO2S2
Acta Crystallographica Section E (2005) 61, 8 o2426-o2427
a=15.043(2)Å b=4.9119(7)Å c=17.1097(17)Å
α=90.00° β=123.848(8)° γ=90.00°
3-(1H-Imidazol-1-yl)-1-(4-methoxyphenyl)propan-1-one
C13H14N2O2
Acta Crystallographica Section E (2005) 61, 8 o2585-o2586
a=21.349(6)Å b=5.2657(14)Å c=21.303(6)Å
α=90.00° β=97.600(4)° γ=90.00°
1-(4-Chlorophenyl)-3-(1H-imidazol-1-yl)propan-1-one
C12H11ClN2O
Acta Crystallographica Section E (2005) 61, 8 o2659-o2660
a=10.4902(9)Å b=8.1611(7)Å c=13.8691(12)Å
α=90.00° β=107.2520(10)° γ=90.00°
(4RS,6SR)2-amino-6-phenyl-4-p-tolyl-5,6-dihydro-4H-1,3-thiazin-3-ium chloride
C17H19N2S,Cl
Acta Crystallographica Section E (2006) 62, 9 o3667-o3669
a=12.0026(15)Å b=14.5838(17)Å c=18.364(2)Å
α=90.00° β=90.00° γ=90.00°
3-(Benzotriazol-1-yl)-1-(4-chlorophenyl)-1-oxopropan-2-yl 2-chlorobenzoate
C22H15Cl2N3O3
Acta Crystallographica Section E (2006) 62, 10 o4348-o4349
a=10.112(2)Å b=9.2772(19)Å c=21.998(5)Å
α=90.00° β=92.773(3)° γ=90.00°
3-(1H-Benzotriazol-1-yl)-1-(4-methoxyphenyl)propan-1-one
C16H15N3O2
Acta Crystallographica Section E (2006) 62, 12 o5801-o5802
a=10.0442(17)Å b=9.7562(17)Å c=14.443(2)Å
α=90.00° β=90.254(3)° γ=90.00°
3-(1H-Benzotriazol-1-yl)-1-(2-fluorophenyl)propan-1-one
C15H12FN3O
Acta Crystallographica Section E (2006) 62, 12 o5453-o5454
a=15.551(6)Å b=5.971(2)Å c=14.221(6)Å
α=90.00° β=104.339(6)° γ=90.00°
3-(Benzotriazol-1-yl)-1-m-tolylpropan-1-one
C16H15N3O
Acta Crystallographica Section E (2007) 63, 3 o1084-o1085
a=14.761(5)Å b=5.794(2)Å c=31.206(9)Å
α=90.00° β=90.00° γ=90.00°
1-(3,4-Dichlorophenyl)-3-(1<i>H</i>-1,2,4-triazol-1-yl)propan-1-one
C11H9Cl2N3O
Acta Crystallographica Section E (2007) 63, 7 o3063-o3063
a=6.8296(10)Å b=7.1403(11)Å c=12.3933(19)Å
α=80.830(2)° β=78.724(2)° γ=75.612(2)°
3-(Benzotriazol-2-yl)-1-(biphenyl-4-yl)propan-1-one
C21H17N3O
Acta Crystallographica Section E (2007) 63, 7 o3091-o3091
a=13.313(3)Å b=10.661(3)Å c=13.629(3)Å
α=90° β=116.739(4)° γ=90°
3-(1H-Benzotriazol-1-yl)-1-(4-bromophenyl)propan-1-one
C15H12BrN3O
Acta Crystallographica Section E (2007) 63, 8 o3602-o3602
a=7.2310(8)Å b=8.1517(9)Å c=12.5240(14)Å
α=101.671(2)° β=101.1970(10)° γ=105.443(2)°
2-(1H-Benzotriazol-1-yl)-1-(2-fluorobenzoyl)ethyl isonicotinate
C21H15FN4O3
Acta Crystallographica Section E (2007) 63, 10 o3989-o3989
a=9.743(4)Å b=10.226(4)Å c=10.975(4)Å
α=99.167(5)° β=114.399(5)° γ=103.444(5)°
3-(1H-Benzotriazol-1-yl)-1-(2-fluorobenzoyl)ethyl nicotinate
C21H15FN4O3
Acta Crystallographica Section E (2007) 63, 10 o3949-o3949
a=9.8423(9)Å b=9.9736(10)Å c=11.4000(11)Å
α=64.4590(10)° β=67.1570(10)° γ=76.3130(10)°
2-(1H-Benzotriazol-1-yl)-1-(2-fluorobenzoyl)ethyl benzoate
C22H16FN3O3
Acta Crystallographica Section E (2007) 63, 11 o4499-o4499
a=9.8372(11)Å b=9.8985(12)Å c=11.6126(13)Å
α=115.187(2)° β=101.572(2)° γ=103.929(2)°
2-(1<i>H</i>-Benzotriazol-1-yl)-1-(4-fluorobenzoyl)ethyl nicotinate
C21H15FN4O3
Acta Crystallographica Section E (2007) 63, 12 o4594-o4594
a=10.6707(10)Å b=10.7620(10)Å c=17.2223(17)Å
α=81.199(2)° β=72.270(2)° γ=81.439(2)°
2-(1<i>H</i>-Benzotriazol-1-yl)-1-(4-fluorobenzoyl)ethyl 2,4-dichlorobenzoate
C22H14Cl2FN3O3
Acta Crystallographica Section E (2007) 63, 11 o4192-o4192
a=11.9859(7)Å b=25.1527(16)Å c=13.8358(9)Å
α=90.00° β=98.6470(10)° γ=90.00°
2-(5,7-Dichloroquinolin-8-yloxy)-<i>N</i>,<i>N</i>-diphenylacetamide
C23H16Cl2N2O2
Acta Crystallographica Section E (2007) 63, 12 o4598-o4598
a=9.8942(13)Å b=9.6703(13)Å c=21.152(3)Å
α=90.00° β=93.107(2)° γ=90.00°
2-(1<i>H</i>-Benzotriazol-1-yl)-1-(2-chlorobenzoyl)ethyl 4-methylbenzoate
C23H18ClN3O3
Acta Crystallographica Section E (2008) 64, 8 o1619
a=7.9254(7)Å b=26.151(2)Å c=10.6002(9)Å
α=90.00° β=107.8950(10)° γ=90.00°
(4<i>RS</i>,6<i>SR</i>)-2-Amino-4-(4-methoxyphenyl)-6-phenyl-5,6-dihydro- 4<i>H</i>-[1,3]thiazin-3-ium chloride
C17H19N2OS,Cl
Acta Crystallographica Section E (2007) 63, 9 o3842-o3842
a=8.4686(11)Å b=18.341(2)Å c=11.1313(14)Å
α=90.00° β=102.971(2)° γ=90.00°
3-(1H-Benzotriazol-1-yl)-1-(3-chlorophenyl)propan-1-one
C15H12ClN3O
Acta Crystallographica Section E (2007) 63, 2 o617-o618
a=7.4919(9)Å b=7.9858(10)Å c=11.4486(14)Å
α=92.948(2)° β=96.711(2)° γ=102.841(2)°
3-(Benzotriazol-1-yl)-1-(4-chlorophenyl)-2-(1,2,4-triazol-1-yl)propan-1-one
C17H13ClN6O
Acta Crystallographica Section E (2006) 62, 9 o3854-o3856
a=29.914(7)Å b=8.1198(18)Å c=14.818(3)Å
α=90.00° β=114.462(3)° γ=90.00°
2-(1H-1,2,3-Benzotriazol-1-ylmethyl)-1-(2,4-dichlorobenzoyl)ethyl nicotinate monohydrate
C21H14Cl2N4O3,H2O
Acta Crystallographica Section E (2006) 62, 9 o4067-o4069
a=11.211(3)Å b=13.035(3)Å c=14.231(3)Å
α=90.00° β=92.910(3)° γ=90.00°
3-(1H-Benzotriazol-1-yl)-1-(4-chlorophenyl)propan-1-one
C15H12ClN3O
Acta Crystallographica Section E (2006) 62, 9 o4203-o4204
a=22.183(7)Å b=10.444(3)Å c=12.326(4)Å
α=90.00° β=106.705(5)° γ=90.00°
C15H12FN3O
C15H12FN3O
Acta Crystallographica Section E (2006) 62, 9 o4065-o4066
a=5.9177(14)Å b=7.2815(17)Å c=29.518(7)Å
α=90.00° β=96.776(5)° γ=90.00°
3-(Benzotriazol-1-yl)-1-(p-tolyl)-2-(1H-1,2,4-triazol-2-yl)propan-1-one
C18H16N6O
Acta Crystallographica Section E (2006) 62, 9 o3670-o3671
a=30.972(3)Å b=8.1625(8)Å c=14.6599(14)Å
α=90.00° β=116.9270(10)° γ=90.00°
3-(Benzotriazol-1-yl)-1-p-tolylpropan-1-one
C16H15N3O
Acta Crystallographica Section E (2006) 62, 9 o3712-o3713
a=11.565(4)Å b=5.7481(18)Å c=11.666(4)Å
α=90.00° β=117.309(5)° γ=90.00°
2-(Benzotriazol-1-yl)-1-(4-methylbenzoyl)ethyl 4-ethylbenzoate
C25H23N3O3
Acta Crystallographica Section E (2007) 63, 3 o1076-o1077
a=13.126(3)Å b=19.136(4)Å c=8.771(2)Å
α=90.00° β=102.401(4)° γ=90.00°
2-(Benzotriazol-1-yl)-1-(4-methylbenzoyl)ethyl 2,4-dichlorobenzoate
C23H17Cl2N3O3
Acta Crystallographica Section E (2007) 63, 3 o1078-o1079
a=5.0020(6)Å b=29.782(4)Å c=14.1351(18)Å
α=90.00° β=92.624(3)° γ=90.00°
2-(1H-Benzotriazol-1-yl)-1-(4-chlorobenzoyl)ethyl isonicotinate
C21H15ClN4O3
Acta Crystallographica Section E (2007) 63, 3 o1194-o1195
a=9.902(4)Å b=9.927(4)Å c=10.893(5)Å
α=114.158(6)° β=96.821(6)° γ=99.745(6)°
2-(1H-Benzotriazol-1-yl)-1-(4-fluorobenzoyl)ethyl isonicotinate
C21H15FN4O3
Acta Crystallographica Section E (2007) 63, 10 o4177-o4177
a=18.475(2)Å b=10.3014(13)Å c=19.723(3)Å
α=90.00° β=90.00° γ=90.00°
2-(1H-1,2,3-Benzotriazol-1-ylmethyl)-1-(4-methylbenzoyl)ethyl benzoate
C23H19N3O3
Acta Crystallographica Section E (2006) 62, 10 o4410-o4411
a=9.5987(9)Å b=10.2272(9)Å c=11.4321(10)Å
α=116.4820(10)° β=96.9280(10)° γ=97.4440(10)°
3-(3H-Benzotriazol-1-yl)-1-(2,5-dichlorophenyl)-2-oxopropyl nicotinate
C21H14Cl2N4O3
Acta Crystallographica Section E (2006) 62, 10 o4425-o4426
a=6.1578(14)Å b=10.779(3)Å c=16.166(4)Å
α=105.048(4)° β=93.677(4)° γ=99.606(4)°
C24H18ClNO
C24H18ClNO
Journal of Organic Chemistry (2009) 74, 2862-2865
a=10.750(2)Å b=13.323(3)Å c=13.796(3)Å
α=90.00° β=101.06(3)° γ=90.00°